Science Explorer Back to mapMap
Discussion
Researcher · Universidad de Salamanca · Spain

Alberto Órfão

Alberto Órfão publishes mostly in Hematology, Immunology and Molecular Biology, on topics such as Multiple Myeloma Research and Treatments, Acute Myeloid Leukemia Research and Chronic Lymphocytic Leukemia Research.

ORCID 0000-0002-0007-7230 OpenAlex
World rank
#190,230
of 7,710,434 ranked researchers
Rank in Spain
#2,855
of 204,306
Works
951
Citations
70k
Citations per work
73.1
h-index
95
i10-index 506Top 0.4% in Hematology
Alberto Órfão

What does Alberto Órfão research?

Alberto Órfão's work is mostly in Medicine (38%), Immunology and Microbiology (17%), Biochemistry, Genetics and Molecular Biology (11%).

Health Sciences: 360 works · 37.9% of their workMedicine: 360 works · 37.9% of their workHematology: 162 works · 17.0% of their workGenetics: 78 works · 8.2% of their workOncology: 64 works · 6.7% of their workPathology and Forensic Medicine: 57 works · 6.0% of their workEverything else: 324 works · 34.1% of their workLife Sciences: 266 works · 28.0% of their workImmunology and Microbiology: 160 works · 16.8% of their workImmunology: 160 works · 16.8% of their workBiochemistry, Genetics and Molecular Biology: 107 works · 11.2% of their workMolecular Biology: 107 works · 11.2% of their workTHEIR WORKAlberto Órfão951works
Life Sciences28%Health Sciences38%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine36037.9%
  2. Everything else32434.1%
    1. Immunology and Microbiology16016.8%
    2. Biochemistry, Genetics and Molecular Biology10711.2%
  1. 1Hematology17% of their works
  2. 2Immunology17% of their works
  3. 3Molecular Biology11% of their works
  4. 4Genetics8% of their works
  5. 5Oncology7% of their works
  6. 6Pathology and Forensic Medicine6% of their works

Research topics

Which keywords describe Alberto Órfão's research?

The keywords of their largest research topics: Prognostic Factors, Minimal Residual Disease, Rituximab, Diagnosis Criteria, International Myeloma Working Group, Acute Myeloid Leukemia, AML and Chronic Lymphocytic Leukemia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Prognostic Factors3553 topics
  2. Minimal Residual Disease2382 topics
  3. Rituximab2272 topics
  4. Diagnosis Criteria1421 topic
  5. International Myeloma Working Group1421 topic
  6. AML1331 topic
  7. Acute Myeloid Leukemia1331 topic
  8. Chronic Lymphocytic Leukemia1261 topic
  9. Genomic Aberrations1261 topic
  10. Allergic Disease1021 topic
  11. Mast Cells1021 topic
  12. Classification1011 topic
  13. Lymphoma1011 topic
  14. Acute Lymphoblastic Leukemia961 topic
  15. Childhood Cancer961 topic
  16. NK Cell Recognition721 topic
  17. Natural Killer Cells721 topic
  18. Genetic Mutations631 topic
  19. Primary Immunodeficiency631 topic

Where does Alberto Órfão work?

Alberto Órfão's main affiliation in the publication record is Universidad de Salamanca, Spain.

How many publications and citations does Alberto Órfão have?

OpenAlex counts 951 works and 69,560 citations for Alberto Órfão, an h-index of 95, ranking #190,230 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Alberto Órfão

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Alberto Órfão. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.